Legislative Update for the week of March 18 – 22

By Melissa Reybold, VP of Public Policy

Well, it was a quiet week for GPhA at the Capitol… wait, is it too early for an April Fool’s joke?

It was anything BUT quiet for us this past week. The days were filled with highs and lows. We had two committee hearings pop up with little notice. Amendments were created, stripped, added, removed, and added again. There were some let-downs on the Senate side while it was all rainbows and unicorns on the House side where we have been 100% supported this year. Low and unfair reimbursements for independents is one of the main issues on many of the legislators’ minds this session and the pressure we created was at an all-time high this past week.

HB 1363

After an unsuccessful meeting in the previous week with a committee chairman, our Call to Action resulted in a hearing on HB 1363. They couldn’t ignore all your calls, texts, and emails on the issue. Thank you to everyone for your outreach. Unfortunately, the hearing didn’t go our way. Our bill was gutted and all that was left was language to have an actuarial study. A couple of committee members left the hearing to quickly vote in other meetings so there was no quorum. The meeting adjourned before those members could return. We had the votes. To watch the hearing, click here and fast-forward to 56:00.

SB 198

Several hours before the Senate HHS hearing, we were informed that a House Public Health meeting was scheduled for a Senate bill (SB 198) that was stripped of its original language and replaced with language that will pay independents the average of what chain pharmacies receive in the SHBP. It was presented by Chairman Lee Hawkins, and this was the only bill on the agenda. It passed the committee unanimously.

After it gets voted on the House floor, it heads back over to the Senate for an agree. We will be working hard to get this past the finish line. This started as an amendment to SB 455 but was removed and added to a gutted SB 198. To watch the hearing, click here.

Preparing to move forward

These are the last days of the session. I know the committee meeting was a letdown but please let’s wait to see if any of our other irons in the fire are successful before we send out emails to legislators expressing our disappointment.

Many of you have senators on that committee that went to bat for you, and I have reached out to them personally to thank them. I will also be reaching out to members in those senators’ districts to let them know how hard they fought.

We are regrouping and strategizing for the final week. Be on the lookout in case we have any Calls to Action. There are two session days and one committee day left so let us know if any legislators reach out to you with information that may be vital in this final stretch. The best way to reach me is my cell: 678-485-6126.

2024 Legislative Update Days 1-5

By Melissa Reybold, VP of Public Policy

Georgia’s 2024 legislative session convened on Monday, January 8, and GPhA was there. While no pharmacy specific bills were introduced, legislative days 1 through 5 were busy nonetheless with GPhA engaging in many discussions with legislators and stakeholders. Typically, the first week will highlight the Governor’s initiatives and other target bills from lawmakers so these first few days were light in terms of pharmacy legislation.

The yearly Georgia Chamber’s Eggs & Issues breakfast was Wednesday morning. Governor Kemp announced plans to appropriate funding towards transportation, infrastructure, housing, a medical school at UGA, and dental school at Georgia Southern. He also put the brakes on tort reform deciding that rewriting Georgia’s litigation rules will likely take longer than one legislative session.

While Eggs & Issues was going on, I attended the Georgia Board of Pharmacy meeting over at the Mercer School of Pharmacy. AIP’s VP, Jonathan Marquess, and Tuxedo Pharmacy owner and GPhA member, Dawn Sasine, were all in attendance with me front and center. Chuck Page gaveled in his first meeting as the president of the board. The open session consisted of rule waiver petitions, approval of minutes and the GDNA report. Ideas on outreach for the Board of Pharmacy’s newsletter were batted around with GPhA volunteering to help. Once the Board of Pharmacy resumes their newsletter, we will gladly help distribute it to our members to keep them in the loop. And just an FYI, the Board of Pharmacy posts events, public hearings, and important information on their page so keep it on your lists of websites to check every so often. For now, click here to view previous Board of Pharmacy newsletters.

As previously mentioned, pharmacy movement was light last week, but one bill did advance with a unanimous vote on Thursday afternoon. At the Senate Regulated Industries and Utilities committee meeting, Representative John LaHood presented HB 455 which would provide that professional programs relating to career fatigue and wellness in healthcare professionals are not obligated to report to licensing boards except in certain circumstances. Representative LaHood introduced this bill in 2023 and GPhA offered input on the language relating to pharmacists. This bill will now head to Rules with Senator John Albers as the sponsor on the Senate side.

This week there is no session as lawmakers work on the state budget, but the work continues as we have numerous meetings with stakeholders and legislators to advance our initiatives.

Legislative Update Crossover

Crossover was Monday, March 6, with hundreds of bills waiting to get called in Rules so they could be eligible for a floor vote.  Unfortunately, our bill did not get called but we are not done yet.  We are currently looking for a crossed over germane bill that we can attach our prescription adaptation bill to keep it in play.   

Last year, we were able to get $250,000 in the budget for an audit of the managed care companies. Recently, it was sent out for bid on the Georgia Procurement Registry. The companies are currently under evaluation and the contract should be awarded soon.

 

Here are some of the bills that we are following…

 

HB416 – Pharmacies; authorize qualified pharmacy technicians to administer certain vaccines

GPhA Past President, Sharon Sherrer, and GPhA Tech of the Year, Heather McCleod, came down to the Capitol and testified in front of the House Health Committee in favor of the tech vaccine bill. Their incredible testimonies garnered unanimous votes from the committee to advance the bill to the next stage. The bill made it through Rules and a House floor vote and is now on the Senate side.

 

HB343 – Lowering Prescription Drug Costs for Patients Act; enact

HB 343 will require PBMs to calculate defined cost sharing for insureds at the point of sale.  This bill has crossed over and was in a “hearing only” in the Senate Health Committee this week.   

 

HB85 – Insurance; require health benefit policy coverage for biomarker testing if supported by medical and scientific evidence

GPhA is supporting this legislation as well. Chairman Cooper is carrying this bill which would require health insurance companies to cover comprehensive biomarker testing which can help pinpoint the type of cancer and exact treatment after being diagnosed. This type of blood and tissue testing can eliminate a lot of the “let’s try this treatment/medicine” which can waste precious time during a cancer diagnosis.  This bill passed the Senate HHS Committee and is going to Senate Rules.

HB143 – Community Health, Department of; include continuous glucose monitors as a pharmacy benefit for Medicaid recipients; require    

This bill will require the Department of Community Health to include continuous glucose monitors as a pharmacy benefit for Medicaid recipients. This bill has crossed over and is now on the Senate side.

 

HB417 – Insurance; prohibit insurers from discriminating against certain healthcare facilities and providers in connection with provider administered drugs

This bill looks to reign in “white bagging” practices and is sponsored by Representative David Knight. Unfortunately, this bill was one of the many that did not get called in Rules on Crossover.    

 

HB332 – Controlled substances; Schedules I. IV, and V; provide certain provisions

This is the yearly drug update bill sponsored by Chairman Parrish and Chairman Stephens. This bill is currently waiting on a vote on the Senate side.

HB181 – Controlled Substances; mitragynine and hydroxymitragynine are Schedule I; provide

Representative Rick Townsend and the American Kratom Association worked together to come up with compromises on this bill. There will be stricter labeling and products will have to be behind the counter. The age has increased to 21 to buy and possess Kratom. The concentration ratio of mitragynine and hydroxymitragynine have certain limits as well.  This bill is now on the Senate side.

 

HB155 – Professions and businesses; issuance of licenses by endorsement for spouses of firefighters, healthcare providers, and law enforcement officers who relocate to Georgia; provide

This bill will allow the spouses of firefighters, healthcare providers, and law enforcement officers who relocate to Georgia to get their professional license within 90 days of date of receipt of an application as long as previous license was in good standing and not the subject of an investigation. This bill has crossed over to the Senate side.

 

HB440 – Education; authorize public and private schools to stock a supply of undesignated ready-to-use glucagon

 

This bill would allow public and private schools in Georgia to stock and administer glucagon to people with diabetes. Nurses and physicians would be able to rapidly administer these crucial medications in an emergency. This legislation would also allow a public or private school to work directly with glucagon manufacturers or third-party suppliers to obtain the products for free or at fair market or reduced prices. 

 

SB76 – State Employees’ Health Insurance Plan; state health benefit plans to cover insulin medication at a reduced rate; provide

 

This Senate bill will cap the cost of insulin at $35 for State Employees.  It has crossed over and on the House side now.

 

SB197 – “Health Care Practitioners Truth and Transparency Act”; enact

 

Senator Hufstetler introduced this legislation for health care providers to identify and not misrepresent their credentials to patients or in advertisements. In a health care setting where there are multiple types of providers, the health care practitioner shall wear an identifier during all patient encounters that includes the health care practitioner’s name and the type of license or educational degree in sufficient size and worn in a conspicuous manner as to be visible and apparent. Also, the health care practitioner will have to announce what their specialty is (ex. I’m Dr. Smith, Doctor of Pharmacy). Penalties are left up to the board under which the offender is licensed.

 

HB557 – Professions and businesses; authority to certain nurses and physician assistants to prescribe Schedule II controlled substances; authorize

 

Chairman Ron Stephens sponsored introduced this bill to authorize physicians to delegate authority to APRNs and PAs to prescribe Schedule II narcotics. The prescription will be limited not to exceed a 5 day supply for individuals 18 and over except for ADHD patients as long as delegating physicians are pediatricians, family practice, internal medicine or psychiatrists. 

 

HB196 – Georgia Access to Medical Cannabis Commission; subject to Administrative Procedure Act and laws governing open meetings and records; provide

 

This bill looks to expand production, increase transparency, and end lawsuits associated with the licenses.  Pharmacies will be able to carry low THC but a subsequent retail license will be required.

 

– Melissa Reybold, VP of Public Policy 

 

 

2023 Legislative Update Week 4 (Days 9-12)

Seems like everyone is anxiously waiting for the dam to burst under the Gold Dome. We expected things to pick up significantly in Week 4 with longer floor sessions, more committee hearings, and hundreds of newly dropped bills to read through but it was another unusually slow week at the Capitol. GPhA was busy with meetings, drafting legislation and discussing issues with stakeholders. We met with legislators to voice our concerns regarding bills that are not favorable to the pharmacy profession as well. We are anticipating some movement with our agenda in Week 5. Stay tuned for next week’s update for bills we will be following during this legislative session.     

— Melissa Reybold, VP of Public Policy

 

2023 Legislative Update Week 3 (Days 5-8)

There were no new developments in Week 3 with any of our agenda items. In fact, the overall feeling of a ‘calm before the storm’ looms under the Gold Dome right now. Legislative Counsel has drafted over 1,000 bills already but less than 20% have been introduced. Committees are still getting organized, and some are convening just to introduce committee members and adopt rules.

The House and Senate met for a joint session on Wednesday for Governor Kemp’s annual State of the State address. His session priorities include focusing on education, improving healthcare, tackling crime, and investing in Georgia’s workforce.

This week, GPhA will have continued conversations regarding our list of priorities. We have also been busy working with legislators and other stakeholders on relevant legislation that may have an impact on the pharmacy profession. We expect things to pick up significantly before next week’s Legislative Update.   

 – Melissa Reybold, VP of Public Policy

DEA Drug Take-Back Day

The DEA’s next National Prescription Drug Take-Back Day is April 30, 2022 – 10 a.m. to 2 p.m. across the state! Georgia citizens have two options on how to participate in the National Prescription Drug Take-Back Day. The two options are:

  1. Use a  “Drive-Up Location” on April 30 between the hours of 10:00 a.m. to 2:00 p.m. To locate a participating DEA National Take-Back Initiative “Drive-Up Location” please click on this link – https://takebackday.dea.gov/. Note: These sites do not include the over 230 Drug Drop Boxes pointed out in #2.  
  2. Your second option is to use one of the more than 230 Drug Drop Boxes across the state in your local law enforcement or pharmacy-maintained drug dropbox. PLEASE be aware that the DEA website DOES NOT list all the Drug Drop Boxes across the state therefore to locate the nearest Drug Drop Box location visit this website: http://prescriptiondrugdisposal.com.

 

Please feel free to share this YouTube video throughout your community to Educate Your Community about the need to dispose of prescription drugs properly; https://www.youtube.com/watch?v=UbjU4LVQzBI.  

 

I have also included the DEA’s Get Smart About Drugs flyer below. Additionally, you will want to see the new Rx Drug Misuse, Abuse, Addiction, and Overdose Prevention Toolkit by clicking HERE or visit this link https://www.canva.com/design/DAEsoWlSwoA/lxH1iCay21fKNhIqoZfN9g/view?utm_content=DAEsoWlSwoA&utm_campaign=designshare&utm_medium=link&utm_source=sharebutton#1.

 

Thank You,

John Bringuel, MA, ICPS

Statewide Project Director

Georgia Prescription Drug Abuse Prevention Initiative

The Council on Alcohol and Drugs

2022 Legislative Update Days 32-35

Sine Die is next Monday and unfortunately, it looks like HB 1351 will not make it to the finish line.  

GPhA is grateful for all of your calls and emails to Senators and Senate leadership over the last several weeks. The pharmacist’s response was phenomenal and we received positive feedback from several senators as a result of your calls. 

On a positive note, consistent with GPhA’s initial legislative priority, there has been some money allocated in the budget for a pass-through dispensing fee and talks are going on in the hopes of maintaining and increasing the allocation in the final budget.

HB1591

One bill that has garnered national attention is from one of our own, Representative Ron Stephens.  HB 1591 looks to add a sub-paragraph relating to the definition of racketeer-influenced and corrupt organizations to read as follows…

“(D) ‘Racketeering activity’ shall also mean the assessment of a retroactive fee or clawback by a pharmacy benefits manager, pharmacy services administrative organization, or insurance company on a pharmacy after a claim has been adjudicated, other than for fraud.”  

This bill was introduced after crossover and so it is not viable to pass this year though with the attention it has received, it may shape policy and legislation in the months and years to come. Also, it made the PBMs sweat a little!

 

HR 823

House Study Committee on Pharmacy Deserts

This week there will be a press conference with State Representatives Sandra Scott (D-Rex), Kim Schofield (D-Atlanta), and Viola Davis (D-Stone Mountain) at the Capitol to discuss Three Key “Deserts” for Underserved Communities which includes pharmacies and how a lack of access has been a longstanding problem across the state. 

HB 963

Controlled substances; Schedule I and IV; change certain provisions

Annual drug bill.  Passed and waiting for Governor’s signature.

HB 1276

Community Health, Department of; statistical reports data relating to state health plans be posted on department website

Representative Hawkins’ bill that requires statistical reports relating to state health plans and prescription drug spending be posted on the department website.  Passed through the House and waiting on a Senate vote. 

HB 1279

Controlled substances; certain persons to carry prescription medications in a compartmentalized container

Representative Matthew Gambill’s bill will allow anyone with a chronic disease or anyone over age 65 who have been prescribed one or medications by a physician to carry their prescriptions in a compartmentalized container with the capacity to hold up to a 21 day supply.  This bill is waiting on a Senate vote.            

 

SB 341

Healthcare Services; guidelines for the prior authorization of a prescribed medication for chronic conditions requiring ongoing medication therapy

Senators Kirkpatrick, Burke, Watson and Hufstetler’s bill provides guidelines for the prior authorization for chronic conditions requiring ongoing medication therapy under certain circumstances to prevent, diagnose, treat or relieve symptoms of a chronic condition for at least a year.   This bill is waiting to be signed by the Governor. 

HB 867

Truth in Prescription Pricing for Patients Act

This bill is waiting on a Senate committee vote.  GPhA will continue to monitor and support this bill.  

 

If you have any questions, please reach out to me at mreybold@gpha.org

Melissa Reybold

 

 

Legislative Update – Days 28-31

Crossover was last Tuesday and luckily, our bill already made it out of the house so we didn’t have the stress of waiting and watching all day and night like some of the others. We are still waiting for a hearing to be scheduled in the Senate Insurance and Labor Committee. It’s getting down to the wire now with only eight legislative days left after today! Some of the bills we have been monitoring did not make it through crossover but that doesn’t necessarily mean that the bill is dead. Sometimes the language in a bill that did not crossover will get inserted into another bill.

HB 1351

Community Health, Department of; pharmacy benefits management for Medicaid program
HB 1351 passed in the House with unanimous votes. We are waiting for a committee hearing. Please continue to call your senator and ask for the support of this bill.

HB 1519

Insurance; prohibit insurers from unilaterally changing network participation contracts impacting coverage, access to, or costs of ancillary services
Representative Knight sponsored this bill which will prohibit insurers from unilaterally changing network participation contracts impacting coverage, access to, or costs of ancillary services, which includes pharmacy services. This bill was assigned to the House Special Committee on Access to Quality Healthcare and passed with unanimous votes. This bill did not make it through Crossover.
HB 1279
Controlled substances; certain persons to carry prescription medications in a compartmentalized container
Representative Matthew Gambill’s bill will allow anyone with a chronic disease or anyone over age 65 who have been prescribed one or medications by a physician to carry their prescriptions in a compartmentalized container with the capacity to hold up to a 21 day supply. This bill was heard in the House Health and Human Services Committee where GPhA offered comments regarding the language in the bill. It passed via substitute with unanimous votes in the committee as well as the House. It will now head to the Senate Public Safety Committee but a hearing has not been scheduled.
SB 256
County Boards of Health; comprehensive reorganization
This bill will prohibit the sale of OTC cough syrup containing dextromethorphan to anyone under 18 years of age. GPhA will continue to monitor this legislation.

HB 1453
Crimes and offenses; access to medical cannabis
Representative Sharon Cooper and Representative Micah Gravely are the main sponsors of this bill which looks to revise provisions regarding access to medical cannabis and to provide for accreditation of independent laboratories for testing low THC oil and products. Also, this bill would provide for additional Class 1 and Class 2 production licenses and transfer the operation and maintenance of the Low THC Oil Patient Registry from the Department of Community Health to the Georgia Composite Medical Board. This bill did not make it through Crossover.
Bills we are continuing to monitor…
HB 867
Truth in Prescription Pricing for Patients Act
GPhA testified in support of this bill last Friday morning in the Senate Insurance and Labor Committee hearing. This was a hearing only so no votes were cast. GPhA will continue to monitor and support this bill.

SB 341
Healthcare Services; guidelines for the prior authorization of a prescribed medication for chronic conditions requiring ongoing medication therapy
Senators Kirkpatrick, Burke, Watson and Hufstetler’s bill provides guidelines for the prior authorization for chronic conditions requiring ongoing medication therapy under certain circumstances to prevent, diagnose, treat or relieve symptoms of a chronic condition for at least a year. GPhA testified in support of this bill last week at the Health and Human Services hearing and it passed with unanimous votes. This bill is now is headed to the House.

HB 902
Insurance; reduce out-of-pocket costs for consumers requiring insulin
This bill would limit total cost of insulin not to exceed $100 for a 30-day supply regardless of the amount or type of insulin needed to fill a covered person’s prescription. This bill did not make it through Crossover.

 

HR 823
House Study Committee on Pharmacy Deserts
A creation of a House study committee on identifying pharmacy deserts within the state and to find solutions to eliminate them. This study will examine programs in Georgia and other states and look for sources of revenue for pharmacy desert programs.
HB 963
Controlled substances; Schedule I and IV; change certain provisions
The annual drug bill passed through both chambers and is waiting on the Governor’s signature.
SB 518
“Prescription Drug Rebate Financial Protection Act”
This bill was introduced by Senator Hufstetler which requires all health insurers to pass along no less that 80 percent of all prescription drug rebates to enrollees that such insurer receives from 3rd parties relating to prescription drugs. This bill did not make it through Crossover.
HB 1276
Community Health, Department of; statistical reports data relating to state health plans be posted on department website
Representative Hawkins’ bill that requires statistical reports relating to state health plans and prescription drug spending be posted on the department website. Passed through the House and was heard in the Senate Insurance and Labor committee hearing last Friday.
HB 1400
Georgia Access to Medical Cannabis Commission; subject to state procurement laws
This bill increases the Class I production licenses from 2 to 9 in 100,000 square feet of cultivation space and increases the Class II production licenses from 4 to 19 in 50,000 square feet of cultivation space. This bill did not make it through Crossover.

If you have any questions, please reach out to me at mreybold@gpha.org.
Melissa Reybold

Press Release Mahlon Davidson voted GPhA President-Elect

Covington pharmacist Mahlon Davidson voted GPhA President-Elect

Covington, Georgia (March 10, 2020) – Covington pharmacist Mahlon Davidson was elected by the Georgia Pharmacy Association Board of Directors as president-elect. The organization is Georgia’s largest and most influential trade association for pharmacists. Davidson will serve as president of the association beginning June 2021.

“For 34 years, I have had the pleasure of being a member of America’s strongest state pharmacy association,” said Davidson, a resident of Oxford, Ga. “This is now my opportunity to give back to the profession and to my fellow pharmacists by serving as an advocate, and an energetic representative of our rapidly changing professional environments.”
Davidson has cared for the Covington and Conyers communities for the past three decades and has served patients of Covington’s Kroger Pharmacy for the past 20 years.

The University of Georgia College of Pharmacy graduate and preceptor has been a member of GPhA since 1985, serving two terms as president of Region 5 and as chair of the Third Party Policy Committee from 2001 to 2006. Davidson was a founding member of the Academy of Employed Pharmacists (AEP), serving as chair from 2002 to 2003 and honored for his vital role with a Pharmacist of the Year award.

“Pharmacists are a critical part of improving healthcare for Georgians,” said Bob Coleman, GPhA CEO. “We’re thrilled Mahlon will ensure the continuity of our strong leadership as we advocate to improve quality of life and healthcare choices for all Georgians at the Capitol.”

Davidson has a long history of leadership. He has also served on the commission on Pharmacy Practice Act Revision in 1997; chaired the PharmPAC Board of Directors; and chaired the Pharmacy Membership Linkage Committee from 2016 to 2017.

About the Georgia Pharmacy Association

The Georgia Pharmacy Association represents Georgia’s pharmacists, pharmacy technicians, and their patients. The trade association advocates with legislators to provide Georgians better healthcare through expanded choice, as well as top tier continuing education for thousands of pharmacists in independent pharmacies, chain pharmacies, hospitals and educational institutions. GPhA members have access to networking and resources to improve their practice and patients’ lives every day. For more information and the latest pharmacy news, visit GPhA.org or follow the organization on Facebook, LinkedIn, Twitter or Instagram.

Press Release Sharon Deason

Sharon Deason of Newnan selected for Georgia Pharmacy Foundation Board of Directors

Retired pharmacist Sharon Deason, RPh was selected to serve on The Georgia Pharmacy Foundation Board of Directors. Deason, who has lived in Newnan for more than 40 years, will begin her 3-year term this month, filling the seat of outgoing board member Liza Chapman.

“Whether helping elderly patients understand their medications or teaching the newly diagnosed diabetic how to inject insulin and manage his lifestyle, the practice of pharmacy has been my passion,” Deason said. “I pledge to do my best to continue the great work of the foundation.”

The nonprofit Georgia Pharmacy Foundation funds student pharmacist scholarships, offers free continuing education (CE) and resources to stay mentally well, and gives pharmacists a free path to become a Champion for Opioid Safety.

“We know Sharon will do much to enhance the foundation’s ongoing growth and commitment to make a difference for Georgia pharmacists and our patients,” said foundation Chairman Jim Bartling.

Deason served as a pharmacist in various settings for 45 years and retired in August of 2019, ending her career in the Newnan community where she most recently served patients at Newnan Plaza Pharmacy. She graduated with Magna Cum Laude honors from the University of Georgia with a Bachelor of Science in Pharmacy.

Deason fills the seat of Liza Chapman, whose 2nd term ends June 2020.

“I have enjoyed working with the fellow board members moving the mission of the Foundation forward in our great state,” Chapman said.

“On behalf of the GPhF Board, I want to express our sincere appreciation for all Liza has done as a member,” Bartling said.

Joe Ed Holt My Story

Joe Ed My story

My Story
Joe Ed Holt, RPh

 

Greetings all fellow members of GPhA,
 
My name is Joe Ed Holt, RPh and I am the chair of PharmWell, a subcommittee of the Georgia Pharmacy Foundation.  Many of you have heard my story of recovery from addiction.  When I was laying there in a psychiatric facility not knowing what my next move was (if there was a next move), I was given a number to call, which put me in contact with the PharmAssist program, which is now under the PharmWell umbrella. Soon, a network of volunteers began contacting me to accomplish one goal: to save my life. That was 20 years ago, and because of their efforts I am still clean and sober today.

We are currently in the process of retooling the PharmAssist program to meet the current needs of our fellow brethren as they face their battles with chemical dependency and addiction, but we need help. We need a network of volunteers who would be willing to help walk beside our fellow pharmacists and offer support and accountability. We need you.

If you have a heart for helping those with addiction issues, please consider joining us in trying to save the lives of those in our profession who may be in a very dark place. We need people that are willing to invest time in making and receiving phone calls, answering questions, or just to be there to listen*. We also need people with ideas. We are still in the planning stages with a launch date very soon, but would like the thoughts and opinions of others as we try to do the best we can in helping those who need help.

If you are interested , please consider emailing me (joeedholt@gmail.com). I’ll contact you back ASAP and let you know where you can help.

Thank you in advance for being willing to help those who may have given up on themselves.

Sincerely, 

Joe Ed Holt, RPh
Georgia Pharmacy Foundation Vice-chair
PharmWell Workgroup Chair

*Some volunteer roles may require additional training or certifications.

Press Release Liza Chapman

Liza Chapman Chairman Georgia Pharmacy FoundationNovember 2, 2020

The Georgia Pharmacy Foundation is happy to announce Dr. Liza Chapman as chairman, effective immediately. Liza is currently Vice President of Partnership Development for the Pharmacy Technician Certification Board, better known in the industry as PTCB. Prior to joining PTCB, Liza was the pharmacy clinical sales coordinator and residency site coordinator with the Kroger Company in Atlanta, Georgia, where she was employed for over 15 years.

Liza is a graduate of Mercer University College of Pharmacy and has been licensed since 2002. She has earned APhA certifications in diabetes, dyslipidemia, immunization delivery, and MTM, and is a certified trainer for APhA’s diabetes immunization, and MTM certificate programs. Her track record as a researcher, guest speaker, and CPE instructor is extensive, and she has been published in the Journal of the American Pharmacists Association and has authored chapters in Introduction to the Pharmacy Profession and Community and Clinical Pharmacy Services: A Step-by-Step Approach. In addition, she has been widely recognized as a pharmacy and community leader and has been awarded a number of honors for her work here in Georgia.

When Georgia first considered authorizing pharmacists to administer influenza vaccines under a protocol agreement with physicians, Dr. Chapman took the leading role as GPhA’s spokesperson and volunteer advocate for passage of that law. Her work helped pave the way for expanding the range of immunizations pharmacists can administer in Georgia without a prescription in 2015.

For all of the above and more, Liza was recognized and became an APhA Fellow in 2017. Liza has served in various capacities with GPhA including GPhA President. By now, you should be aware that Liza is an extraordinary leader, person, and role model for the pharmacy profession. Welcome back, Liza!

“We are deeply saddened by the passing of our dear colleague and friend, Dr. Jim Bartling, who served the Georgia Pharmacy Foundation for many years.  I can never fill Jim’s shoes, but I am honored to have the opportunity to serve again on the Foundation board and continue the legacy that Jim has created.”

-Liza Chapman, PharmD, FAPhA

###

The Georgia Pharmacy Association represents Georgia’s pharmacists, pharmacy technicians, and their patients. We fight for pharmacists at the capitol.  We provide education, networking, and resources to improve pharmacy practice — and patients’ lives — every day. For more information and the latest pharmacy news, visit GPhA.org.

The Georgia Pharmacy Foundation is the nonprofit arm of the Georgia Pharmacy Association, which represents the state’s pharmacists, pharmacy technicians, and their patients. The foundation’s mission is to advance the quality of healthcare for patients in Georgia communities through the profession of pharmacy.

 

Media Contact:
Michelle Turkington
Georgia Pharmacy Association
Director of Marketing and Communications
6065 Barfield Road NE, Suite 100
Sandy Springs, Georgia 30328
mturkington@gpha.org
678-640-4313

 

COVID-19 Therapeutics Allocations for Feb 28 – Mar 6, 2022

From: HHS – Coordination Operations and Response Element (H-CORE), Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services  

Subject: COVID-19 therapeutics allocations for Feb 28 – Mar 6, 2022
Importance: High

 

Dear Stakeholder,  

Allocation amounts for COVID-19 therapeutics to states, territories, and federal entities have been determined for the period of Feb 28 – Mar 6, 2022, and are below. Evusheld, Bebtelovimab and Sotrovimab are included in today’s allocations. 

On Feb 24, FDA announced a modification to the Emergency Use Authorization for Evusheld (AstraZeneca). The modification involves a change to the dosing regimen.  Evusheld now should be administered as an initial dose of 600 mg. Individuals who already received the previously authorized initial 300 mg dose should receive a second Evusheld dose as soon as possible. Recommendations will be made in the near future when more data are available to determine the appropriate timing of redosing (e.g., a repeat dose with 150 mg of tixagevimab and 150 mg of cilgavimab at 3 months or 6 months after the initial dose). 

HHS is committed to the health and wellbeing of all Americans, and that is why we have purchased as much Evusheld as the manufacturer can supply. We are making product available to states and territories without delay. Current utilization data available to us (as reported by state and territorial health departments and administration sites) notes the utilization rate of Evusheld is approximately 20% nationally with orders of Evusheld also being low. We are focused on outreach efforts to help increase utilization across jurisdictions and make Evusheld more available to providers for use among eligible patients as another tool for protection against COVID-19. To support product access, we maintain a public dashboard of jurisdiction-by-jurisdiction allocations of Evusheld as well as an online locator

Distribution Determinations for Feb 28 – Mar 6, 2022
Units = doses 

The allocation dashboard can also be found on ASPR. HHS.gov.  

Jurisdiction 

Evusheld 

Bebtelovimab 

Sotrovimab 

Total 

Alabama 

744 

845 

762 

2351 

Alaska 

120 

185 

168 

473 

American Samoa 

Arizona 

1032 

1480 

1326 

3838 

Arkansas 

456 

715 

642 

1813 

BOP 

California 

5904 

6090 

5466 

17460 

Colorado 

840 

840 

750 

2430 

Connecticut 

552 

355 

318 

1225 

Delaware 

144 

120 

120 

384 

Dept of Defense 

390 

408 

798 

Dept of State 

District of Columbia 

120 

100 

120 

340 

Federated States of Micronesia 

Florida 

3240 

4050 

3636 

10926 

Georgia 

1536 

1385 

1242 

4163 

Guam 

Hawaii 

216 

195 

174 

585 

HRSA 

ICE 

Idaho 

240 

620 

558 

1418 

Illinois 

1944 

1345 

1206 

4495 

Indian Health Svc 

408 

390 

408 

1206 

Indiana 

984 

840 

756 

2580 

Iowa 

480 

405 

366 

1251 

Kansas 

432 

420 

378 

1230 

Kentucky 

672 

1625 

1458 

3755 

Louisiana 

696 

675 

606 

1977 

Maine 

216 

920 

828 

1964 

Marshall Islands 

Maryland 

912 

455 

408 

1775 

Massachusetts 

1080 

785 

708 

2573 

Michigan 

1512 

1310 

1176 

3998 

Minnesota 

840 

760 

684 

2284 

Mississippi 

456 

380 

342 

1178 

Missouri 

912 

910 

816 

2638 

Montana 

168 

350 

312 

830 

Nebraska 

288 

210 

186 

684 

Nevada 

432 

345 

306 

1083 

New Hampshire 

216 

270 

240 

726 

New Jersey 

1368 

935 

840 

3143 

New Mexico 

312 

355 

318 

985 

New York 

3048 

1880 

1686 

6614 

NIH 

24 

20 

24 

68 

North Carolina 

1536 

2090 

1878 

5504 

North Dakota 

120 

140 

126 

386 

Northern Mariana Islands 

Ohio 

1776 

1265 

1134 

4175 

Oklahoma 

576 

715 

642 

1933 

Oregon 

624 

655 

588 

1867 

Palau 

Pennsylvania 

1992 

1650 

1482 

5124 

Puerto Rico 

528 

155 

144 

827 

Rhode Island 

168 

115 

120 

403 

South Carolina 

768 

965 

870 

2603 

South Dakota 

120 

210 

186 

516 

Tennessee 

1008 

1715 

1536 

4259 

Texas 

4032 

4795 

4308 

13135 

U.S. Virgin Islands 

24 

100 

120 

244 

Utah 

408 

480 

432 

1320 

Vermont 

96 

120 

120 

336 

Veterans Health 

390 

408 

798 

Virginia 

1296 

1325 

1188 

3809 

Washington 

1104 

695 

624 

2423 

West Virginia 

288 

605 

546 

1439 

Wisconsin 

888 

750 

672 

2310 

Wyoming 

96 

100 

120 

316 

Grand total 

49,992 

51,990 

46,986 

148,968 

For questions regarding COVID-19 therapeutics for this cycle, please contact COVID-19Therapeutics@hhs.gov.  

Thank you,  

HHS – Coordination Operations and Response Element (H-CORE)  

Office of the Assistant Secretary for Preparedness and Response  

U.S. Department of Health and Human Services  

 

VOTE YES FOR HB 1351

ATTENTION INDEPENDENT PHARMACISTS AND PHARMACY OWNERS!

THE FIGHT FOR PRESCRIPTION DRUG MEDICAID MANAGED CARE CARVE-OUT IS ON!

Dear GPhA/AIP Member,

Representative Knight’s Medicaid Carve-Out Bill, HB 1351, has been introduced and will be heard by the House Special Committee on Access to Quality Healthcare today at 3:00 pm.  The stakes for independent pharmacy in Georgia couldn’t be higher and the MCOs and PBMs are coming out in force to kill this legislation.    

Please reach out to every member of the Special Committee on Access to Quality Healthcare committee members via phone or email TODAY and let them know:

  1. PBM and MCO practices are putting your pharmacy in jeopardy;
  2. PBM and MCOs continue to engage in opaque drug pricing and benefit management practices including retroactive fees and patient steering;
  3. HB 1351 will;
    1. Take away prescription drug benefit administration from Medicaid MCOs;
    2. Increase transparency and fairness by putting prescription drug benefits back info Medicaid FFS where most drugs are reimbursed at NADAC + a fair dispensing fee based on pharmacy costs to dispense; and
    3. A carve-out will increase transparency, reign in abusive practices, and treat pharmacies and patients fairly.

Finally,

  1. ASK THEM TO SUPPORT MEDICAID CARVE-OUT EFFORTS AND VOTE YES FOR HB 1351

Special Committee on Access to Quality Healthcare

david.knight@house.ga.gov  404.463.2248

patty.bentley@house.ga.gov  404.656.0287

sharon.cooper@house.ga.gov  404.656.5069

john.corbett@house.ga.gov  404.656.5105

spencer.frye@house.ga.gov  404.656.0265

matt.hatchett@house.ga.gov  404.656.5025

penny.houston@house.ga.gov  404.463.2248

todd.jones@house.ga.gov  404.463.2246

randy.nix@house.ga.gov  404.656.5146

butch.parrish@house.ga.gov  404.463.2246

clay.pirkle@house.ga.gov  404.656.7850

brian.prince@house.ga.gov  404.656.0116

richard.smith@house.ga.gov  404.656.5141

calvin.smyre@house.ga.gov  404.656.0109

mark.newton@house.ga.gov  404.656.7853

 

You can watch the committee hearing here.

 

Thank you!

Bob Coleman
CEO
Georgia Pharmacy Association

Press Release Tim Short Running for District 28 State Representative

FOR IMMEDIATE RELEASE
January 26, 2022

Media Contact:
info@votetimshort.com
(404) 291-2652

CUMMING, GA – Long-time local pharmacist and business owner, Tim Short, RPh, has announced his campaign for Georgia State House in the newly-drawn GA-28 district for portions of Hall and Forsyth Counties.

“I am running to represent and preserve the conservative values of our district,” announced Short.  “With the decline in leadership and the lack of integrity in our political system over the last few years, I am motivated to provide an honest, straightforward, and trustworthy voice in our state Capitol.”

Short has been a resident of Forsyth County since 1981. He raised his family, built a business, and served in leadership roles within his profession. As the owner of an independent pharmacy, he has also served a role in government affairs and most recently helped inform legislation that lowered costs and improved pharmacy benefits for every Georgian.

Spending his career listening to people, Tim focuses on the big picture and makes decisions that benefit his customers, his profession, and the community at large. “I want to put my knowledge and experience to work as a resource in our legislature. As a father, grandfather, business owner, and leader, I have a vested interest in addressing the day-to-day concerns of every citizen in this district.”  Short points to the priorities that he believes every resident of Forsyth and Hall counties share in common as issues he wants to address under the gold dome – including transparency, education, controlled growth, community safety and security, and economic opportunity.

Short is a lifelong Georgian, a graduate of the University of Georgia, and opened Sawnee Drug Company in 1988. Throughout his career, Short has served as a member, leader, and Chairman within the boards of various organizations including the Georgia Pharmacy Association, Academy of Independent Pharmacy, PharmPAC,  National Community Pharmacy Association, and the American Pharmacy Association. He has served on committees dedicated to member benefits and governmental affairs and has been recognized as AIP Pharmacist of the year.

Tim and his wife Rita have two sons and one grandson. They continue to reside in Forsyth County and attend Browns Bridge Church where Tim has taken on additional leadership and service roles.

###

Older Posts ▶